All In Biotech

Free tool

FAERS Monitor: Activella

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022001 or its brand name (Activella, Estradiol, Norethindrone Acetate). Reports on generic versions are filed under their own applications.

Reports

1,888

Serious

1,434

76% of reports

Hospitalization

391

Death reported

37

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • breast cancer282
  • breast cancer female191
  • fatigue96
  • nausea94
  • headache80
  • dizziness75
  • pain69
  • drug ineffective68
  • off label use64
  • feeling abnormal60
  • arthralgia58
  • diarrhoea56
  • anxiety53
  • hot flush51
  • depression48

Reports by year received

View as table
YearReports
200427
200569
200681
2007155
200862
2009151
2010158
201142
201238
201345
201435
201563
201664
201740
201856
201964
2020103
202190
2022104
2023119
2024106
2025119
202697

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,271 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer femaleSignal19180.270.114,776
breast cancerSignal28233.830.48,958
hot flushSignal517.55.8284
feeling abnormalSignal602.82.268
depressionSignal482.41.836
anxietySignal532.11.629
dizziness751.71.320
arthralgia581.61.211
headache801.41.110
fatigue961.41.110
nausea941.31.17
pain691.31.03
diarrhoea561.00.70
off label use640.80.63
drug ineffective680.60.522

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.